Video: A Clinical Trial Explaining DCIS

Since all DCIS is not the same as regards malignant potential, Dr. Shelley Hwang describes a clinical trial that will hopefully provide some answers.

Where the DCIS contains hormone receptors, patients may be treated three months prior to surgery to monitor response to medical (hormonal) therapy and some may not even need surgery, or where a mastectomy may have been needed, it may be possible to conserve the breast.

Interviewee:

Shelley Hwang MD, MPH, Chief Breast Surgical Oncology UCSF Helen Diller Family Comprehensive Cancer Center 

This video was originally published on BeetMedicine.TV.

Comments

[Halsey]

Glad for the work the Dr. is doing...da­rn it all...I got the rare triple negative (no hormone receptors)­...out of the blue...no family history, white (it hits primarily Black women)...a­nd it's nasty...as is its treatment, ACT then radiation.­.. I just hope some lab has my 4 inch tumor and are working on IT!..